Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, van Luijk P, Vissink A, van der Laan BF, Leemans CR, Bijl HP, Christianen ME, Steenbakkers RJ, Langendijk JA. Beetz I, et al. Among authors: van der schaaf a, van luijk p, van der laan bf, van den heuvel er. Radiother Oncol. 2012 Oct;105(1):101-6. doi: 10.1016/j.radonc.2012.03.004. Epub 2012 Apr 18. Radiother Oncol. 2012. PMID: 22516776 Free article.
Statistical validation of normal tissue complication probability models.
Xu CJ, van der Schaaf A, Van't Veld AA, Langendijk JA, Schilstra C. Xu CJ, et al. Among authors: van der schaaf a, van t veld aa. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e123-9. doi: 10.1016/j.ijrobp.2012.02.022. Epub 2012 Apr 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 22541961
The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, Rasch CR, van 't Veld AA, van der Schaaf A, Schilstra C, Langendijk JA; Rococo cooperative group. van der Laan HP, et al. Among authors: van de water ta, van der schaaf a, van t veld aa, van herpt he. Acta Oncol. 2013 Apr;52(3):561-9. doi: 10.3109/0284186X.2012.692885. Epub 2012 Jun 19. Acta Oncol. 2013. PMID: 22708528
Development and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in head and neck cancer.
Wopken K, Bijl HP, van der Schaaf A, Christianen ME, Chouvalova O, Oosting SF, van der Laan BF, Roodenburg JL, Leemans CR, Slotman BJ, Doornaert P, Steenbakkers RJ, Verdonck-de Leeuw IM, Langendijk JA. Wopken K, et al. Among authors: van der schaaf a, van der laan bf. PLoS One. 2014 Apr 15;9(4):e94879. doi: 10.1371/journal.pone.0094879. eCollection 2014. PLoS One. 2014. PMID: 24736318 Free PMC article.
Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K. Morimoto M, et al. Among authors: van der schaaf a. Tumori. 2014 May-Jun;100(3):265-71. doi: 10.1700/1578.17198. Tumori. 2014. PMID: 25076236
Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG, Korevaar EW, Steenbakkers RJ, Janssen T, van't Veld AA, Langendijk JA, Schilstra C, van der Schaaf A. Kierkels RG, et al. Among authors: van der schaaf a, van t veld aa. Radiother Oncol. 2014 Sep;112(3):430-6. doi: 10.1016/j.radonc.2014.08.020. Epub 2014 Sep 11. Radiother Oncol. 2014. PMID: 25220369
130 results